Caption Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$30.2M Buy
+103,000
New +$33.9M 0.18% 122
2025
Q1
Sell
-10,000
Closed -$3.69M 1656
2024
Q4
$3.69M Buy
+10,000
New +$4.18M 0.03% 473
2021
Q3
Sell
-23,000
Closed -$8.78M 1588
2021
Q2
$8.78M Buy
+23,000
New +$8.79M 0.11% 227
2020
Q3
Sell
-37,500
Closed -$9.86M 1085
2020
Q2
$9.86M Buy
+37,500
New +$10M 0.33% 58

Other funds holding ELV

Caption Management's ELV Position: Q1 2026 in Review

Caption Management increased its Elevance Health (ELV) stake by 198% in Q1 2026, buying an estimated $1.4M and bringing the position to 6,400 shares worth $1.87M. The position accounts for 0.01% of the portfolio, ranked #839.

Caption Management first reported a position in ELV in Q2 2020 and has held it in 6 quarters since. The position peaked at $5M in Q2 2020. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Caption Management held 6,400 shares of Elevance Health worth $1.87M as of Q1 2026.
  • Caption Management bought 4,250 Elevance Health shares in Q1 2026, an estimated $1.4M.
  • Elevance Health made up 0.01% of Caption Management's portfolio in Q1 2026, its #839 holding.
  • Caption Management first reported a position in Elevance Health in Q2 2020 and has held it in 6 quarters since.
  • Caption Management's Elevance Health position peaked at $5M in Q2 2020.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.